COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 195 filers reported holding COHERUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $477,496 | -49.4% | 127,676 | -42.3% | 0.00% | 0.0% |
| Q2 2023 | $944,041 | +66996.0% | 221,087 | +7.4% | 0.00% | -50.0% |
| Q1 2023 | $1,407 | -9.2% | 205,773 | +5.2% | 0.00% | 0.0% |
| Q4 2022 | $1,549 | -99.9% | 195,614 | +4.5% | 0.00% | -33.3% |
| Q3 2022 | $1,798,000 | +37.8% | 187,106 | +3.8% | 0.00% | +50.0% |
| Q2 2022 | $1,305,000 | -38.8% | 180,303 | +9.2% | 0.00% | -33.3% |
| Q1 2022 | $2,131,000 | -14.5% | 165,100 | +5.8% | 0.00% | 0.0% |
| Q4 2021 | $2,491,000 | -1.7% | 156,108 | -1.0% | 0.00% | 0.0% |
| Q3 2021 | $2,535,000 | -1.1% | 157,748 | -14.9% | 0.00% | 0.0% |
| Q2 2021 | $2,563,000 | -6.8% | 185,349 | -1.5% | 0.00% | -25.0% |
| Q1 2021 | $2,749,000 | -10.9% | 188,167 | +6.0% | 0.00% | 0.0% |
| Q4 2020 | $3,085,000 | -1.3% | 177,514 | +4.2% | 0.00% | -20.0% |
| Q3 2020 | $3,125,000 | -3.8% | 170,370 | -6.4% | 0.01% | 0.0% |
| Q2 2020 | $3,250,000 | +95.5% | 181,963 | +77.6% | 0.01% | +66.7% |
| Q1 2020 | $1,662,000 | -12.9% | 102,485 | -3.3% | 0.00% | 0.0% |
| Q4 2019 | $1,908,000 | -7.9% | 105,958 | +3.7% | 0.00% | -25.0% |
| Q3 2019 | $2,071,000 | -11.7% | 102,205 | -3.7% | 0.00% | 0.0% |
| Q2 2019 | $2,346,000 | +92.3% | 106,161 | +18.7% | 0.00% | +100.0% |
| Q1 2019 | $1,220,000 | +97.4% | 89,415 | +31.0% | 0.00% | +100.0% |
| Q4 2018 | $618,000 | -14.3% | 68,251 | +56.1% | 0.00% | 0.0% |
| Q3 2018 | $721,000 | +14.3% | 43,718 | -3.0% | 0.00% | 0.0% |
| Q2 2018 | $631,000 | +60.6% | 45,081 | +26.9% | 0.00% | 0.0% |
| Q1 2018 | $393,000 | +23.2% | 35,532 | -1.8% | 0.00% | 0.0% |
| Q4 2017 | $319,000 | -44.1% | 36,197 | -15.4% | 0.00% | 0.0% |
| Q3 2017 | $571,000 | -5.9% | 42,792 | +1.2% | 0.00% | 0.0% |
| Q2 2017 | $607,000 | -20.7% | 42,282 | +16.9% | 0.00% | -50.0% |
| Q1 2017 | $765,000 | -15.7% | 36,177 | +12.3% | 0.00% | 0.0% |
| Q4 2016 | $907,000 | +13.8% | 32,208 | +8.2% | 0.00% | 0.0% |
| Q3 2016 | $797,000 | +65.0% | 29,775 | +4.1% | 0.00% | +100.0% |
| Q2 2016 | $483,000 | +0.8% | 28,595 | +26.8% | 0.00% | 0.0% |
| Q1 2016 | $479,000 | -7.2% | 22,559 | +0.5% | 0.00% | -50.0% |
| Q4 2015 | $516,000 | +24.0% | 22,454 | +8.2% | 0.00% | +100.0% |
| Q3 2015 | $416,000 | -27.7% | 20,749 | +4.3% | 0.00% | -50.0% |
| Q2 2015 | $575,000 | – | 19,885 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |